annual SGA:
$154.34M+$5.15M(+3.45%)Summary
- As of today (June 22, 2025), HALO annual SGA is $154.34 million, with the most recent change of +$5.15 million (+3.45%) on December 31, 2024.
- During the last 3 years, HALO annual SGA has risen by +$104.01 million (+206.69%).
- HALO annual SGA is now at all-time high.
Performance
HALO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$42.36M+$113.00K(+0.27%)Summary
- As of today (June 22, 2025), HALO quarterly SGA is $42.36 million, with the most recent change of +$113.00 thousand (+0.27%) on March 31, 2025.
- Over the past year, HALO quarterly SGA has increased by +$7.23 million (+20.57%).
- HALO quarterly SGA is now -26.30% below its all-time high of $57.48 million, reached on June 30, 2022.
Performance
HALO quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$1.50B+$310.59M(+26.20%)Summary
- As of today (June 22, 2025), HALO TTM SGA is $1.50 billion, with the most recent change of +$310.59 million (+26.20%) on March 31, 2025.
- Over the past year, HALO TTM SGA has increased by +$1.35 billion (+918.03%).
- HALO TTM SGA is now at all-time high.
Performance
HALO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
HALO Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.5% | +20.6% | +918.0% |
| 3 y3 years | +206.7% | +206.2% | +2717.6% |
| 5 y5 years | +99.8% | +235.3% | +1981.4% |
HALO Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +206.7% | -26.3% | +206.2% | at high | +384.6% |
| 5 y | 5-year | at high | +237.4% | -26.3% | +306.3% | at high | +163.2% |
| alltime | all time | at high | >+9999.0% | -26.3% | >+9999.0% | at high | +159.9% |
HALO Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $42.36M(+0.3%) | $161.56M(+4.7%) |
| Dec 2024 | $154.34M(+3.5%) | $42.25M(+2.4%) | $154.34M(+3.1%) |
| Sep 2024 | - | $41.24M(+15.5%) | $149.69M(+4.2%) |
| Jun 2024 | - | $35.71M(+1.6%) | $143.72M(-2.2%) |
| Mar 2024 | - | $35.13M(-6.6%) | $146.96M(-1.5%) |
| Dec 2023 | $149.18M(+3.9%) | $37.61M(+6.6%) | $149.18M(-0.1%) |
| Sep 2023 | - | $35.27M(-9.4%) | $149.32M(+0.5%) |
| Jun 2023 | - | $38.95M(+4.3%) | $148.52M(-11.1%) |
| Mar 2023 | - | $37.36M(-1.0%) | $167.05M(+16.4%) |
| Dec 2022 | $143.53M(+185.2%) | $37.75M(+9.5%) | $143.53M(+20.1%) |
| Sep 2022 | - | $34.47M(-40.0%) | $119.55M(+21.7%) |
| Jun 2022 | - | $57.48M(+315.5%) | $98.25M(+85.0%) |
| Mar 2022 | - | $13.83M(+0.4%) | $53.10M(+5.5%) |
| Dec 2021 | $50.32M(+10.0%) | $13.77M(+4.6%) | $50.32M(+7.1%) |
| Sep 2021 | - | $13.17M(+6.9%) | $46.98M(+3.2%) |
| Jun 2021 | - | $12.32M(+11.4%) | $45.51M(+3.0%) |
| Mar 2021 | - | $11.06M(+6.1%) | $44.16M(-3.4%) |
| Dec 2020 | $45.74M(-40.8%) | $10.43M(-10.9%) | $45.74M(-22.8%) |
| Sep 2020 | - | $11.70M(+6.6%) | $59.24M(-9.6%) |
| Jun 2020 | - | $10.97M(-13.1%) | $65.52M(-8.9%) |
| Mar 2020 | - | $12.63M(-47.2%) | $71.88M(-7.0%) |
| Dec 2019 | $77.25M(+27.1%) | $23.93M(+33.1%) | $77.25M(+8.3%) |
| Sep 2019 | - | $17.98M(+3.7%) | $71.35M(+4.6%) |
| Jun 2019 | - | $17.34M(-3.7%) | $68.24M(+4.6%) |
| Mar 2019 | - | $18.01M(-0.1%) | $65.25M(+7.3%) |
| Dec 2018 | $60.80M(+13.0%) | $18.03M(+21.3%) | $60.80M(+5.7%) |
| Sep 2018 | - | $14.86M(+3.6%) | $57.54M(+2.7%) |
| Jun 2018 | - | $14.35M(+5.9%) | $56.01M(+2.3%) |
| Mar 2018 | - | $13.56M(-8.2%) | $54.76M(+1.7%) |
| Dec 2017 | $53.82M(+17.4%) | $14.77M(+10.8%) | $53.82M(+5.0%) |
| Sep 2017 | - | $13.33M(+1.7%) | $51.27M(+3.5%) |
| Jun 2017 | - | $13.10M(+3.9%) | $49.54M(+3.9%) |
| Mar 2017 | - | $12.62M(+3.2%) | $47.66M(+3.9%) |
| Dec 2016 | $45.85M(+14.6%) | $12.23M(+5.4%) | $45.85M(+3.7%) |
| Sep 2016 | - | $11.60M(+3.4%) | $44.22M(+3.2%) |
| Jun 2016 | - | $11.22M(+3.8%) | $42.84M(+3.4%) |
| Mar 2016 | - | $10.81M(+2.0%) | $41.44M(+3.5%) |
| Dec 2015 | $40.03M(+11.4%) | $10.59M(+3.5%) | $40.03M(+5.9%) |
| Sep 2015 | - | $10.23M(+4.2%) | $37.79M(+4.5%) |
| Jun 2015 | - | $9.81M(+4.4%) | $36.15M(+3.0%) |
| Mar 2015 | - | $9.40M(+12.5%) | $35.09M(-2.4%) |
| Dec 2014 | $35.94M | $8.35M(-2.7%) | $35.94M(-2.7%) |
| Sep 2014 | - | $8.59M(-1.9%) | $36.95M(+1.2%) |
| Jun 2014 | - | $8.75M(-14.6%) | $36.49M(+4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $10.25M(+9.6%) | $35.04M(+8.3%) |
| Dec 2013 | $32.35M(+30.4%) | $9.36M(+15.0%) | $32.35M(+7.9%) |
| Sep 2013 | - | $8.13M(+11.4%) | $29.97M(+9.1%) |
| Jun 2013 | - | $7.30M(-3.4%) | $27.47M(+6.7%) |
| Mar 2013 | - | $7.56M(+8.3%) | $25.75M(+3.8%) |
| Dec 2012 | $24.81M(+37.1%) | $6.98M(+23.9%) | $24.81M(+4.7%) |
| Sep 2012 | - | $5.63M(+1.0%) | $23.70M(+6.1%) |
| Jun 2012 | - | $5.58M(-15.7%) | $22.33M(+4.8%) |
| Mar 2012 | - | $6.62M(+12.8%) | $21.32M(+17.7%) |
| Dec 2011 | $18.10M(+19.7%) | $5.87M(+37.6%) | $18.10M(+7.3%) |
| Sep 2011 | - | $4.26M(-6.7%) | $16.87M(+5.6%) |
| Jun 2011 | - | $4.57M(+34.1%) | $15.98M(+8.2%) |
| Mar 2011 | - | $3.41M(-26.5%) | $14.77M(-2.3%) |
| Dec 2010 | $15.12M(-0.5%) | $4.63M(+37.4%) | $15.12M(+3.6%) |
| Sep 2010 | - | $3.37M(+0.5%) | $14.60M(-2.2%) |
| Jun 2010 | - | $3.36M(-10.6%) | $14.93M(-3.5%) |
| Mar 2010 | - | $3.76M(-8.6%) | $15.47M(+1.8%) |
| Dec 2009 | $15.20M(+3.9%) | $4.11M(+11.0%) | $15.20M(+6.5%) |
| Sep 2009 | - | $3.70M(-5.1%) | $14.27M(+1.8%) |
| Jun 2009 | - | $3.90M(+12.0%) | $14.02M(+0.4%) |
| Mar 2009 | - | $3.49M(+9.7%) | $13.96M(-4.6%) |
| Dec 2008 | $14.63M(+31.2%) | $3.18M(-7.9%) | $14.63M(-5.0%) |
| Sep 2008 | - | $3.45M(-10.3%) | $15.40M(+4.1%) |
| Jun 2008 | - | $3.85M(-7.5%) | $14.79M(+11.0%) |
| Mar 2008 | - | $4.16M(+5.3%) | $13.33M(+19.5%) |
| Dec 2007 | $11.16M(+61.4%) | $3.95M(+39.0%) | $11.16M(+16.4%) |
| Sep 2007 | - | $2.84M(+19.3%) | $9.58M(+17.6%) |
| Jun 2007 | - | $2.38M(+20.0%) | $8.15M(+10.6%) |
| Mar 2007 | - | $1.99M(-16.4%) | $7.37M(+6.6%) |
| Dec 2006 | $6.91M(+102.3%) | $2.38M(+69.2%) | $6.91M(+20.4%) |
| Sep 2006 | - | $1.40M(-12.5%) | $5.74M(+16.1%) |
| Jun 2006 | - | $1.60M(+4.7%) | $4.95M(+19.5%) |
| Mar 2006 | - | $1.53M(+27.3%) | $4.14M(+21.2%) |
| Dec 2005 | $3.42M(+32.9%) | $1.20M(+97.7%) | $3.42M(+12.3%) |
| Sep 2005 | - | $608.10K(-23.7%) | $3.04M(-1.8%) |
| Jun 2005 | - | $797.40K(-1.4%) | $3.10M(+8.0%) |
| Mar 2005 | - | $808.60K(-2.2%) | $2.87M(+11.6%) |
| Dec 2004 | $2.57M(+5200.2%) | $827.20K(+24.4%) | $2.57M(+47.4%) |
| Sep 2004 | - | $664.90K(+17.2%) | $1.74M(+41.5%) |
| Jun 2004 | - | $567.50K(+11.1%) | $1.23M(+66.4%) |
| Mar 2004 | - | $511.00K(+233.3%) | $740.10K(+169.4%) |
| Sep 2003 | - | $153.30K(+102.2%) | $274.70K(+126.3%) |
| Jun 2003 | - | $75.80K(+66.2%) | $121.40K(+166.2%) |
| Mar 2003 | - | $45.60K | $45.60K |
| Dec 2001 | $48.50K | - | - |
FAQ
- What is Halozyme Therapeutics annual SGA?
- What is the all time high annual SGA for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual SGA year-on-year change?
- What is Halozyme Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly SGA year-on-year change?
- What is Halozyme Therapeutics TTM SGA?
- What is the all time high TTM SGA for Halozyme Therapeutics?
- What is Halozyme Therapeutics TTM SGA year-on-year change?
What is Halozyme Therapeutics annual SGA?
The current annual SGA of HALO is $154.34M
What is the all time high annual SGA for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual SGA is $154.34M
What is Halozyme Therapeutics annual SGA year-on-year change?
Over the past year, HALO annual SGA has changed by +$5.15M (+3.45%)
What is Halozyme Therapeutics quarterly SGA?
The current quarterly SGA of HALO is $42.36M
What is the all time high quarterly SGA for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly SGA is $57.48M
What is Halozyme Therapeutics quarterly SGA year-on-year change?
Over the past year, HALO quarterly SGA has changed by +$7.23M (+20.57%)
What is Halozyme Therapeutics TTM SGA?
The current TTM SGA of HALO is $1.50B
What is the all time high TTM SGA for Halozyme Therapeutics?
Halozyme Therapeutics all-time high TTM SGA is $1.50B
What is Halozyme Therapeutics TTM SGA year-on-year change?
Over the past year, HALO TTM SGA has changed by +$1.35B (+918.03%)